News Feature

On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the thinking in his field about what causes a common and often lethal heart defect.

Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.

With no blood flow to his right lung, infant Carter Johnson was diagnosed with a rare condition called absent right pulmonary artery. His parents turned to Stanford Children’s Health for help.

Patients who took statins less than 70 percent of the time had a 20 percent increase in mortality compared with those taking them at least 90 percent of the time, a Stanford study found.

A nurse-scientist at Lucile Packard Children’s Hospital Stanford has discovered a passion for science, and advocates for bringing the nursing perspective into clinical research.

Researchers’ experimental approach for preparing mice for blood stem cell transplantation may one day make it possible in humans to safely transplant organs or cells from any donor to any recipient.

Few medical devices are approved specifically for babies and children. An FDA grant to fund a collaboration between Stanford and UCSF for developing pediatric devices aims to fill the gap.

Stanford researchers find that positive expectations can make children less anxious about mild but uncomfortable symptoms that arise during treatment for peanut allergies.

The researchers found that by testing for fragments of cancer DNA in urine, they could find the cancer in early stages of development, when it’s easier to treat.

In preliminary tests, SAMβA (pronounced “samba”) appears to improve heart functions in rats with heart failure caused by a heart attack.